Abstract

Despite a considerable expansion in the present therapeutic repertoire for other malignancy managements, mortality from head and neck cancer (HNC) has not significantly improved in recent decades. Moreover, the second primary cancer (SPC) diagnoses increased in patients with HNC, but studies providing evidence to support SPCs prediction in HNC are lacking. Several base classifiers are integrated forming an ensemble meta-classifier using a stacked ensemble method to predict SPCs and find out relevant risk features in patients with HNC. The balanced accuracy and area under the curve (AUC) are over 0.761 and 0.847, with an approximately 2% and 3% increase, respectively, compared to the best individual base classifier. Our study found the top six ensemble risk features, such as body mass index, primary site of HNC, clinical nodal (N) status, primary site surgical margins, sex, and pathologic nodal (N) status. This will help clinicians screen HNC survivors before SPCs occur.

Highlights

  • Squamous cell carcinoma of the head and neck is a worldwide cancer, affecting a lot of people and causing deaths

  • Our study revealed that late clinical nodal stage, larger lymph node sizes, lymph node metastasis to level I–III, late combined stage, and late pathologic T stage all contributed to second primary cancer (SPC) occurrence in head and neck cancer (HNC) survivors

  • A stacked ensemble method is firstly applied to predict the important features of SPCs for HNC survivors

Read more

Summary

Objectives

This study aimed to identify the most crucial risk factors from the

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call